DR BERNARD FRITZELL
WYETH VACCINES RESEARCH
Bernard Fritzell, MD is Vice President, International Scientific & Clinical Affairs for Wyeth Vaccines Research, based in Paris, France. Dr Fritzell received his medical degree from the University of Bordeaux with additional diploma in Tropical Diseases, Health and Development, and Statistics applied to Epidemiology and Clinical Research at the University of Bordeaux and the University Pierre & Marie Curie, Paris.
Dr Fritzell has extensive experience in the direction of vaccine clinical trial programmes and medical affairs activities surrounding marketed vaccines. Before joining Wyeth in June 1999, Dr Fritzell held the position of Vice President, Clinical Research and Medical Affairs for Chiron Vaccines in Sienna, Italy. During August 1993 to September 1996, he was Head of Clinical Research for Vaccines at the Pasteur-Mérieux Sérums et Vaccins, Marne-la-Coquette, France.
Dr Fritzell has directed all phases of vaccine development working extensively in both Europe and the USA. Programs have been designed and set-up across Europe, Africa, Asia and the Middle East and have included research into new adjuvants, paediatric and adult combination vaccines, Pneumococcal conjugate, Haemophilus influenzae type b conjugate, Meningococcal A & C conjugate, Typhoid fever, Hepatitis A, Varicella and Zoster, Measles, Rabies, Dengue and Japanese Encephalitis.
Since June 1996, he has been chairman of the clinical working group of the European Vaccines Manufacturers (EVM). EVM was formed in 1991 as a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), and is dedicated to the improvement of public health through immunisation and the promotion of research and development into innovative vaccines. EVM represents major European vaccine producers accounting for the majority of the vaccines used worldwide.
In addition, Dr. Fritzell has also held governmental positions working within the Ministry of Health in Somalia where his responsibilities included the management of a case detection programme for most predominant infectious diseases among state employees and relatives, and Medical Attaché to the French Embassy in Beijing, China.
Dr Fritzell will be presenting Prospects for preventing invasive pneumococcal disease with conjugate vaccines beyond PCV7, including evidence for use in a 2 +1 immunisation schedule, read the abstract here.